Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
640 The combination of COM701 + nivolumab demonstrates preliminary antitumor activity in patients with metastatic breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
